retatrutide triple agonist obesity trial 🚨 HOT OFF THE PRESS: Phase 3 data has arrived — and the medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

While the exact foods and calorie intake vary from person to person, the overall principles remain the same: prioritise quality nutrition, stay hydrated, and build sustainable eating habits that support long-term weight management

After that, this dosage gradually increases once every four weeks until you reach the maximum dose of 2.4 mg

This gives bacteria more time to break down food and produce sulfur-based gases

Because tirzepatide is newer and even fewer human studies exist, the evidence gap is even wider

We are committed to providing innovative and effective solutions for patients seeking to improve their metabolic health and achieve sustainable weight loss

Love to learn more about how it could address non-alcoholic steatohepatitis (NASH) and cardiovascular riskstwo massive unmet needs.